These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11216701)

  • 1. Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: a report from the National Wilms Tumor Study Group.
    Shearer P; Kapoor G; Beckwith JB; Takashima J; Breslow N; Green DM
    J Pediatr Hematol Oncol; 2001 Feb; 23(2):109-11. PubMed ID: 11216701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.
    Sarhan OM; El-Baz M; Sarhan MM; Ghali AM; Ghoneim MA
    Urology; 2010 Oct; 76(4):946-51. PubMed ID: 20708784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
    Kröger N; Zander AR; Martinelli G; Ferrante P; Moraleda JM; Da Prada GA; Demirer T; Socie G; Rosti G;
    Ann Oncol; 2003 Apr; 14(4):554-8. PubMed ID: 12649100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
    Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?
    Pagano L; Pulsoni A; Tosti ME; Mele A; Mele L; Corvatta L; Miraglia E; Almici C; Manna A; Del Poeta G; Lanza F; Masini L; Recchia A; Equitani F; Leone G; Mandelli F;
    Hematol J; 2000; 1(5):329-32. PubMed ID: 11920210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group.
    Breslow NE; Takashima JR; Whitton JA; Moksness J; D'Angio GJ; Green DM
    J Clin Oncol; 1995 Aug; 13(8):1851-9. PubMed ID: 7636528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML.
    de Nully Brown P; Hoffmann T; Hansen OP; Boesen AM; Grønbaek K; Hippe E; Jensen MK; Thorling K; Storm HH; Pedersen-Bjergaard J
    Leukemia; 1997 Jan; 11(1):37-41. PubMed ID: 9001416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
    Feusner JH; Ritchey ML; Norkool PA; Takashima JR; Breslow NE; Green DM
    Pediatr Blood Cancer; 2008 Feb; 50(2):242-5. PubMed ID: 17458877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous bilateral Wilm's tumor with complete radiographic response managed without surgical resection: a report from the National Wilm's Tumor Study 4.
    Hamilton TE; Ritchey ML; Argani P; Beckwith JB; Perlman EJ; Cotton CA; Shamberger RC
    J Pediatr Surg; 2008 Nov; 43(11):1982-4. PubMed ID: 18970928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of secondary leukemias.
    Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
    Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials.
    Pagano L; Pulsoni A; Vignetti M; Tosti ME; Falcucci P; Fazi P; Fianchi L; Levis A; Bosi A; Angelucci E; Bregni M; Gabbas A; Peta A; Coser P; Ricciuti F; Morselli M; Caira M; Foà R; Amadori S; Mandelli F; Leone G;
    Ann Oncol; 2005 Feb; 16(2):228-33. PubMed ID: 15668275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary neoplasms after Wilms' tumor in Germany.
    Nourkami N; Furtwängler R; Alkassar M; Graf N;
    Strahlenther Onkol; 2009 Aug; 185 Suppl 2():11-2. PubMed ID: 19685027
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
    Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
    Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia as a second malignancy: report of 9 pediatric patients in a single institution in Argentina.
    Felice MS; Zubizarreta PA; Chantada GL; Alfaro E; Cygler AM; Gallego M; Rossi J; Sackmann-Muriel F
    Med Pediatr Oncol; 1998 Mar; 30(3):160-4. PubMed ID: 9434824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
    Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
    J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.
    Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD
    Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second primary neoplasms in survivors of Wilms' tumour--a population-based cohort study from the British Childhood Cancer Survivor Study.
    Taylor AJ; Winter DL; Pritchard-Jones K; Stiller CA; Frobisher C; Lancashire ER; Reulen RC; Hawkins MM;
    Int J Cancer; 2008 May; 122(9):2085-93. PubMed ID: 18196579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
    Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.